BE
Bonness Enterprises Portfolio holdings
AUM
$305M
This Quarter Return
+11.69%
1 Year Return
+20.16%
3 Year Return
+82.96%
5 Year Return
+156.72%
10 Year Return
+388.32%
AUM
$217M
AUM Growth
+$217M
(+10%)
Cap. Flow
-$1.05M
Cap. Flow
% of AUM
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
63.58%
Holding
41
New
1
Increased
7
Reduced
7
Closed
–
Top Buys
| 1 |
Organon & Co
OGN
|
$1.38M |
| 2 |
Verizon
VZ
|
$551K |
| 3 |
Pfizer
PFE
|
$154K |
| 4 |
Viatris
VTRS
|
$144K |
| 5 |
Bristol-Myers Squibb
BMY
|
$106K |
Top Sells
| 1 |
Progressive
PGR
|
$3.31M |
| 2 |
Microsoft
MSFT
|
$67.3K |
| 3 |
Coca-Cola
KO
|
$59.2K |
| 4 |
Nucor
NUE
|
$57.1K |
| 5 |
Marsh & McLennan
MMC
|
$17.4K |
Sector Composition
| 1 | Financials | 30.67% |
| 2 | Healthcare | 29.96% |
| 3 | Technology | 25.18% |
| 4 | Consumer Staples | 3.96% |
| 5 | Industrials | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Progressive
PGR
$145B
| $58.9M | 27.2% |
573,653
-32,200
| -5% | -$3.31M |
|
2
Stryker
SYK
$150B
| $18.3M | 8.44% |
68,366
-34
| -0% | -$9.09K |
|
|
3
Microsoft
MSFT
$3.77T
| $15.5M | 7.18% |
46,200
-200
| -0.4% | -$67.3K |
|
4
Apple
AAPL
$3.45T
| $9.76M | 4.51% |
54,940
| – | – |
|
5
Thermo Fisher Scientific
TMO
$186B
| $7.61M | 3.51% |
11,400
| – | – |
|
6
Johnson & Johnson
JNJ
$427B
| $6.68M | 3.08% |
39,038
+100
| +0.3% | +$17.1K |
|
|
7
Nucor
NUE
$34.1B
| $5.35M | 2.47% |
46,850
-500
| -1% | -$57.1K |
|
8
Merck
MRK
$210B
| $5.33M | 2.46% |
69,500
| – | – |
|
9
Cisco
CSCO
$274B
| $5.24M | 2.42% |
82,700
-200
| -0.2% | -$12.7K |
|
10
AbbVie
ABBV
$372B
| $5M | 2.31% |
36,900
+300
| +0.8% | +$40.6K |
|
11
Applied Materials
AMAT
$128B
| $4.93M | 2.27% |
31,300
| – | – |
|
|
12
Pfizer
PFE
$141B
| $4.8M | 2.21% |
81,208
+2,600
| +3% | +$154K |
|
13
Abbott
ABT
$231B
| $4.6M | 2.13% |
32,700
| – | – |
|
14
Intel
INTC
$107B
| $4.58M | 2.12% |
88,950
| – | – |
|
|
15
Marsh & McLennan
MMC
$101B
| $4.47M | 2.06% |
25,700
-100
| -0.4% | -$17.4K |
|
16
Unilever
UL
$155B
| $4.09M | 1.89% |
76,040
| – | – |
|
17
Emerson Electric
EMR
$74.3B
| $4.04M | 1.87% |
43,500
| – | – |
|
18
IBM
IBM
$227B
| $3.94M | 1.82% |
29,464
| – | – |
|
|
19
Bristol-Myers Squibb
BMY
$96B
| $3.42M | 1.58% |
54,800
+1,700
| +3% | +$106K |
|
20
United Parcel Service
UPS
$74.1B
| $3.2M | 1.48% |
14,950
| – | – |
|
21
GSK
GSK
$79.9B
| $2.92M | 1.35% |
66,200
+2,000
| +3% | +$88.2K |
|
22
Agilent Technologies
A
$35.7B
| $2.86M | 1.32% |
17,900
| – | – |
|
23
John Wiley & Sons Class A
WLY
$2.16B
| $2.77M | 1.28% |
48,400
| – | – |
|
24
Procter & Gamble
PG
$368B
| $2.68M | 1.24% |
16,400
| – | – |
|
|
25
Verizon
VZ
$186B
| $2.47M | 1.14% |
47,587
+10,600
| +29% | +$551K |
|